The team, led by Zukang Gong of the Fifth People’s Hospital of Nanning together with colleagues from Guangxi Medical University and the Nanning Center for Disease Control and Prevention, surveyed 1,050 patients at a mental health hospital in a southern province of China. Each participant completed three standardized instruments: the Self-Rating Anxiety Scale to measure anxiety severity, the Mania Scale to capture elevated mood, irritability, and increased activity, and the Activities of Daily Living Disability Scale to quantify how much help patients needed with self-care and routine functioning. Ethical approval came from the Medical Ethics Committees of Guangxi Medical University and the Fifth People’s Hospital of Nanning, and all participants gave informed consent in line with the Declaration of Helsinki.

What makes the study methodologically interesting is its departure from the traditional epidemiological habit of treating symptoms as isolated variables. Instead, the researchers used network analysis, a statistical framework borrowed in part from complexity science, in which each symptom or functional impairment is a node and the statistical associations between them are edges. In such a network, some nodes act as hubs with many strong connections, while others sit at the periphery. The analysis revealed a dense web of interactions linking daily living limitations, mania, and anxiety, with limitations in activities of daily living emerging as a particularly influential node. It was both a strong direct predictor of anxiety and a bridge through which other symptoms exerted their effects, a role the authors describe as mediating within the network structure.

Network analysis, however, describes correlations; it cannot by itself establish the direction of influence. To probe that question, the team turned to path analysis, a form of structural equation modeling that tests whether data are consistent with hypothesized causal chains. Two indirect routes stood out. In the first, daily living limitations increased anxiety by first intensifying mania symptoms, with the indirect component of this effect accounting for 33.2 percent of the total effect. In the second, mania symptoms worsened anxiety partly by eroding patients’ capacity to manage daily tasks, a pathway responsible for 16.2 percent of the total effect. In plain terms, roughly one third of the way that functional impairment translates into anxious distress runs through heightened manic states, and about one sixth of the way mania breeds anxiety runs through lost independence.

These bidirectional pathways paint a picture of a self-reinforcing cycle that clinicians will recognize from the ward. A patient who struggles to wash, dress, or feed independently may experience frustration, agitation, and restless energy that resemble or trigger manic symptoms. Those manic states, characterized by impulsivity and disorganized behavior, can in turn make it harder to maintain basic routines, deepening the functional impairment. Anxiety thrives in this environment, fed both directly by the loss of autonomy and indirectly by the escalating mood instability. The synergy implied by the study’s title is precisely this: neither daily living limitations nor mania alone tells the full story of anxiety risk, but together they form a loop in which each aggravates the other.

The study also found that the strength of these pathways is not uniform across the patient population. Gender and age acted as moderating variables, meaning the indirect effects linking daily living limitations, mania, and anxiety differed in magnitude depending on who the patient was. The authors do not report that one single pathway dominates in every subgroup; rather, their conclusion emphasizes that the three constructs are interrelated and exhibit differential path mechanisms across gender and age. That heterogeneity matters for practice. A screening strategy that treats all psychiatric patients as equivalent with respect to anxiety risk may miss those whose vulnerability is concentrated in a particular pathway, such as younger patients whose mania-driven route to anxiety is especially strong, or older patients for whom functional decline plays a larger role.

For the researchers, the motivation was a gap in the literature. Mental disorders have become a global public health challenge with a continuously expanding patient population, yet most studies of anxiety risk have focused on the general population, leaving psychiatric patients comparatively understudied. That gap is consequential because anxiety in people already living with mental disorders is associated with worse prognosis, greater functional decline, and higher service use. By focusing specifically on a hospitalized psychiatric sample and by modeling symptoms as an interacting system rather than a list of independent predictors, the study offers a more realistic account of how distress accumulates in this vulnerable group.

The clinical implications follow directly from the structure of the findings. If a substantial share of anxiety risk flows through functional impairment and mania, then interventions that preserve or restore daily living skills could do double duty, easing anxiety both directly and by dampening the manic symptoms that mediate part of the effect. Occupational therapy, structured daily routines, and rehabilitation programs aimed at self-care might therefore be reframed not merely as supportive care but as anxiety prevention. Conversely, aggressive management of manic symptoms could protect patients’ functional independence and, through it, reduce anxious distress. The moderating roles of gender and age suggest that these interventions should be tailored rather than uniform, with assessments that identify which pathway is most active for each individual patient.

As with any cross-sectional survey, caution is warranted in interpreting the directionality. Path analysis tests whether observed data are consistent with a proposed causal architecture, but it cannot prove causation in the way a randomized experiment can, and the mediation percentages describe statistical decomposition rather than measured biological mechanisms. The sample came from a single hospital in one province of China, which raises fair questions about generalizability to other settings and cultures. The study also relied on self-report scales, which, while validated and widely used, are subject to reporting biases that may vary with symptom state. The authors themselves frame the work as evidence that the three constructs are interrelated and warrant joint attention, a claim the data support robustly, rather than as a definitive causal verdict.

Even with those caveats, the study adds a compelling piece to a growing body of research that treats psychopathology as a network of mutually reinforcing symptoms rather than a collection of separate disorders. Its quantitative decomposition of the anxiety risk into direct and indirect components, and its demonstration that the balance of those components shifts with demographic characteristics, gives clinicians and researchers a concrete target: break the loop between lost daily function and mania, and anxiety may lose much of its fuel. For a patient population that has long been underserved by research designed around healthier populations, that reframing is a practical step toward care that addresses the whole system a patient lives in, not just the diagnosis on the chart.

Subject of Research: Synergistic effects of daily living limitations and mania symptoms on anxiety risk in patients with mental disorders

Article Title: Anxiety risk from the synergistic effect of activities of daily living limitations and mania symptoms in mental disorder patients: evidence from network and path analysis

Article References: Gong, Z., Liu, S., Xu, B., Qin, S., Lan, L., Long, J., Chen, B., Shen, B., Huang, X., Liang, T., Liao, F., Su, L., & Lin, W. (2026). Anxiety risk from the synergistic effect of activities of daily living limitations and mania symptoms in mental disorder patients: evidence from network and path analysis. BMC Psychiatry. https://doi.org/10.1186/s12888-026-08600-1

Image Credits: AI Generated

DOI: 10.1186/s12888-026-08600-1

Keywords: anxiety, mania, activities of daily living, mental disorders, network analysis, path analysis, psychiatry, mediation effect, functional impairment, gender differences, age differences, BMC Psychiatry

The research team, led by corresponding author Jianfei Shi, set out to answer a question that has lingered in the literature on bipolar disorder for years. Impairments in theory of mind have been documented across mood states in bipolar disorder, and they appear to deepen during manic episodes. What has remained murky is the neurophysiological sequence behind those impairments, particularly the timing between two stages of mental-state reasoning: an earlier, posterior stage thought to handle perspective-related processing, and a later, frontal stage involved in selecting among perspectives and managing the conflicts that arise when another person’s viewpoint clashes with one’s own. Behavior alone cannot separate these stages; only a technique with fine temporal resolution can.

That technique is electroencephalography, or EEG, which records electrical activity at the scalp with millisecond precision. From the continuous EEG signal, researchers can extract event-related potentials, stereotyped waves of brain activity time-locked to specific events in a task. In this study, nineteen patients who met ICD-10 diagnostic criteria for a bipolar manic episode and twenty-four healthy controls completed a rapid theory of mind judgment task while their brain activity was recorded. The design was deliberately fast-paced, forcing participants to compute and apply mental-state inferences under time pressure, which is closer to the demands of real social life than the leisurely judgments used in many earlier studies.

The behavioral results confirmed what clinicians observe at the bedside. Compared with healthy controls, the patients with bipolar disorder showed reduced accuracy and prolonged reaction times across all conditions of the task. In other words, they were both slower and less accurate when asked to reason about another person’s perspective, a double deficit that suggests the difficulty is not simply a matter of hesitation or caution but of genuinely impaired computation. Notably, the patients’ manic symptoms were subthreshold at the time of assessment according to established cutoffs on the Young Mania Rating Scale, meaning the participants were not in an acute, severe episode, yet the social-cognitive differences were still measurable.

The electrophysiological findings are where the study makes its most distinctive contribution. The researchers focused on two components. The first, dubbed TP450, spans roughly 325 to 525 milliseconds after a stimulus and is associated with posterior perspective-related processing, drawing on regions toward the back and side of the brain, including areas near the temporoparietal junction that have long been implicated in reasoning about other minds. The second, the late frontal slow wave, or LFSW, spans roughly 600 to 800 milliseconds and is treated as a marker of later frontal processing during perspective selection and conflict management, engaging the prefrontal systems that govern control and decision-making.

When the two groups were compared, a clear dissociation emerged. The patients showed significantly attenuated TP450 amplitudes at right parietal electrode sites, specifically at the P4 position, consistent with altered processing in the posterior network that assembles perspective-related information in the first place. They also exhibited reduced LFSW amplitudes at left frontal sites, at electrode F3, consistent with altered recruitment of the later frontal machinery that selects among perspectives and resolves conflicts between them. The deficit, in other words, was not confined to a single stage. Both the early assembly of social information and the later executive application of that information appeared to be blunted in the patient group.

This two-stage picture matters because it helps distinguish between two broad hypotheses about social-cognitive impairment in bipolar disorder. One possibility is that patients fail at the representational level: they cannot build an adequate model of another person’s mental state. The other is that the model is built adequately but then applied poorly, especially when the patient’s own perspective competes with the other person’s. The concurrent reduction of both the TP450 and the LFSW in this sample suggests that the application phase of theory of mind, not merely the representational phase, is compromised, and that the temporal handoff between posterior and frontal systems may be a key point of failure. The authors frame this as preliminary evidence for differences in posterior perspective-related processing and subsequent frontal processing during theory of mind application.

The methodological care behind these conclusions is worth appreciating. The study was approved by the Ethics Committee of Hangzhou Seventh People’s Hospital and conducted in accordance with the Declaration of Helsinki, with written informed consent obtained from all participants or their legal guardians. It was registered in the National Medical Research Registration and Filing Information System of China. Standard EEG preprocessing practices, including independent component analysis, were applied to clean the data, and neuropsychological measures such as the digit span test and verbal fluency test were used to characterize the participants’ broader cognitive profiles. The work was partly supported by the Construction Fund of Key Medical Disciplines of Hangzhou.

At the same time, the researchers are candid about the limits of what they can claim. The patient sample comprised only nineteen individuals, a small clinical cohort by any standard, and the manic symptoms were subthreshold rather than severe at the time of testing. The authors explicitly state that the findings require replication in larger, independent samples before they can be generalized to the broader population of people with bipolar disorder. Small ERP studies are vulnerable to sampling variability, and effect sizes at individual electrode sites can shift between cohorts. The results should therefore be read as a well-controlled first signal rather than a settled answer, a signal that nonetheless points in a theoretically coherent direction.

If the findings do replicate, the implications could extend well beyond the laboratory. Theory of mind deficits are strongly linked to real-world functioning in bipolar disorder, influencing relationship stability, occupational performance, and the ability to recognize when one’s own judgment is drifting. A temporal marker such as the TP450 or the LFSW could eventually serve as an objective index of social-cognitive state, potentially helping clinicians track recovery across mood episodes or evaluate whether an intervention is restoring not just mood but the neural machinery of social understanding. The study also adds bipolar disorder to the growing list of conditions, from autism to schizophrenia, in which the fine-grained choreography of perspective taking can now be watched in real time, one electrical oscillation at a time.

Subject of Research: Neural mechanisms of theory of mind application deficits in bipolar mania measured with event-related potentials

Article Title: Neural mechanisms underlying theory of mind application deficits in bipolar mania: an event-related potential study

Article References: Zhou, J., Zhou, X., Zhang, K., Wang, C., Li, X., & Shi, J. (2026). Neural mechanisms underlying theory of mind application deficits in bipolar mania: an event-related potential study. BMC Psychiatry. https://doi.org/10.1186/s12888-026-08652-3

Image Credits: AI Generated

DOI: 10.1186/s12888-026-08652-3

Keywords: bipolar disorder, mania, theory of mind, event-related potentials, EEG, TP450, late frontal slow wave, perspective taking, social cognition, temporoparietal junction, prefrontal cortex, BMC Psychiatry

The methodological heart of the study lies in its commitment to data-driven phenotyping. Rather than assuming in advance which symptom clusters matter, the researchers applied K-means clustering to 174 individual clinical items drawn from validated instruments, including the Patient Health Questionnaire-9, the Generalized Anxiety Disorder-7, the Young Mania Rating Scale, the Hypomania Checklist-32, the Snaith-Hamilton Pleasure Scale, the Insomnia Severity Index, the Dysfunctional Attitudes Scale, and measures of non-suicidal self-injury and psychotic symptoms rated on the Brief Psychiatric Rating Scale. Clustering at the level of individual questionnaire items, rather than summed scale scores, allowed the algorithm to detect combinations of symptoms that cut across conventional diagnostic boundaries. The procedure produced two stable, non-overlapping transdiagnostic phenotypes, and the cluster solution held up under internal validation using the adjusted Rand index.

The first group was labeled the Negative Affect-Anhedonic phenotype. Its defining features were self-injurious tendencies together with depressive and anhedonic symptoms — the withdrawal, joylessness, and despair that most people associate with severe depression, but which in this sample appeared in patients carrying either diagnosis. The second group, the Manic-Activation phenotype, was characterized by manic and hypomanic activation: elevated mood, heightened drive, reduced need for sleep, and accelerated thinking and behavior. Crucially, each phenotype drew members from both diagnostic camps. A patient with a bipolar diagnosis could belong to the negative affect cluster, and a patient diagnosed with unipolar depression could show prominent manic-activation features. The researchers report that phenotype dominance only partially aligned with categorical diagnosis, revealing substantial cross-diagnostic overlap and equally substantial heterogeneity within each diagnosis.

With the symptom phenotypes established, the team turned to the brain. All participants underwent high-resolution 3 Tesla structural magnetic resonance imaging, and the scans were processed with FreeSurfer, the widely used reconstruction pipeline, to extract three complementary measures of neuroanatomy: cortical thickness, cortical surface area, and subcortical volumes. These metrics are biologically distinct. Cortical thickness reflects the width of the folded gray matter ribbon and is thought to relate to dendritic arborization and synaptic density, whereas surface area reflects the degree of cortical folding and the expansion of functional columns; the two show largely independent genetic determinants. Subcortical volumes capture structures such as the hippocampus, amygdala, and basal ganglia, regions repeatedly implicated in mood regulation. To relate these anatomical measures to the symptom phenotypes, the researchers used sparse canonical correlation analysis, a multivariate technique that identifies weighted patterns of variables on both sides of the equation that maximally covary with one another — an approach well suited to the complexity of brain-wide morphology paired with multi-item symptom profiles.

The results delivered a clear modality split. Both the Negative Affect-Anhedonic and Manic-Activation phenotypes showed statistically significant multivariate associations with cortical thickness and with cortical surface area, but neither was linked to subcortical volumes in the full sample. Statistical significance was established through permutation testing, and the stability of individual features was verified with bootstrapping, giving the team confidence that the brain-symptom relationships were not artifacts of a single analytic pass. The absence of subcortical findings is itself notable: despite decades of attention to the hippocampus and amygdala in mood disorders, the strongest transdiagnostic signals in this cohort lived in the cortex.

Perhaps the most striking technical finding concerns the spatial organization of the two cortical metrics. The associations involving cortical thickness were focal, concentrated in higher-order association regions — the areas of the cortex that integrate information across sensory modalities and support complex cognition, self-referential processing, and emotion regulation. By contrast, the associations involving cortical surface area were spatially distributed across much of the cortical sheet but appeared to be network-organized, suggesting coordinated maturational or structural variation along the lines of large-scale neural networks rather than isolated regional differences. This thickness-versus-area dissociation matters because the two metrics index different cellular and developmental processes, and the study’s authors interpret the pattern as evidence that transdiagnostic symptom phenotypes map onto partially dissociable, modality-specific structural brain signatures rather than a single undifferentiated anomaly.

The study also tackled a developmental question. Because the sample spanned adolescence and emerging adulthood — a window during which the brain undergoes dramatic cortical thinning and network refinement — the researchers tested whether the strength of brain-symptom associations varied continuously with age in 960 participants aged 10 to 29 years. Six models were examined, crossing each symptom phenotype with each structural modality. The verdict after correction for multiple comparisons was uniformly negative: no age-by-symptom interaction survived false discovery rate correction across the six tested models. The smallest nominal effect appeared in the Negative Affect-Anhedonic model with subcortical volumes, but the authors were explicit that this effect failed to survive correction and should be treated as exploratory only. In a field where developmental moderation claims are often made on nominal p-values, this restrained reporting is a methodological lesson in itself.

The clinical implications are layered. At a practical level, the findings lend empirical weight to dimensional frameworks such as the Research Domain Criteria initiative advanced by the United States National Institute of Mental Health, which encourages researchers and clinicians to study psychopathology along measurable dimensions rather than relying solely on DSM-5 categories. The Wuhan team’s data show that symptom-based phenotypes capture clinically meaningful heterogeneity that categorical diagnoses obscure — two patients with the same diagnostic label can sit in opposite symptom clusters, and two patients with different labels can share a cluster and, potentially, a common cortical profile. That said, the researchers caution that the phenotypes only partially aligned with diagnosis, so the categorical system has not been rendered obsolete; rather, it appears to be an incomplete lens. A multimetric framework that tracks both cortical thickness and surface area, alongside dimensional symptom measures, may better capture the shared and distinct biology of major mood disorders.

There are also important limits to keep in view. The study is cross-sectional, so it can demonstrate that symptom phenotypes and cortical anatomy covary, but not that one causes the other — cortical differences could predispose to particular symptom patterns, chronic illness could reshape the cortex, medications could contribute, or a third factor could drive both. The clustering solution, while internally stable, represents one data-driven cut through a vast symptom space, and alternative algorithms or item sets might yield different groupings. And the null developmental findings mean only that no moderation was detectable in this cohort with these methods, not that age is irrelevant to brain-symptom relationships. The study was registered prospectively at the Chinese Clinical Trial Registry (ChiCTR2500106094), received ethics approval from Renmin Hospital of Wuhan University, and was funded by the National Key R&D Program of China and the National Natural Science Foundation of China, among other sources.

Even with those caveats, the scale and rigor of the work make it a landmark in the effort to connect the messy, overlapping reality of mood disorder symptoms to measurable brain structure. By showing that data-derived symptom phenotypes — not diagnostic labels — align with reproducible, modality-specific patterns of cortical morphology in more than a thousand patients, the study offers a template for how large clinical cohorts, item-level machine learning, and multivariate neuroimaging statistics can be combined to move psychiatry beyond its century-old categories. The next step, the researchers and their colleagues in the field will likely agree, is longitudinal: following patients over time to see whether these cortical signatures predict symptom trajectories, treatment response, or the emergence of manic episodes in those who today carry only a depression diagnosis.

Subject of Research: Neuroanatomical correlates of transdiagnostic symptom phenotypes in major depressive and bipolar disorders

Article Title: Neuroanatomical correlates of transdiagnostic clinical phenotypes in major depressive and bipolar disorders

Article References: Lu, X., Hu, M., Luo, D., Hou, H., Feng, M., He, J., Wang, W., Yang, B. X., & Zong, X. (2026). Neuroanatomical correlates of transdiagnostic clinical phenotypes in major depressive and bipolar disorders. BMC Psychiatry. https://doi.org/10.1186/s12888-026-08602-z

Image Credits: AI Generated

DOI: 10.1186/s12888-026-08602-z

Keywords: major depressive disorder, bipolar disorder, transdiagnostic psychiatry, structural MRI, cortical thickness, cortical surface area, K-means clustering, sparse canonical correlation analysis, FreeSurfer, Research Domain Criteria, anhedonia, mania

Bipolar disorder is one of the most disabling psychiatric conditions worldwide, characterized by alternating episodes of depression and mania. Manic episodes involve elevated or irritable mood, inflated self-esteem, decreased need for sleep, racing thoughts, and impulsive behavior, and they frequently require hospitalization. Clinicians currently assess the severity of mania with rating scales such as the Young Mania Rating Scale, or YMRS, and gauge treatment response by observing how those scores decline over weeks of medication. What they lack is a biological marker, something measurable in the body that could predict, early on, whether a given patient is likely to respond well to standard treatment. The new study addresses precisely this gap.

The theoretical backdrop is the oxidative stress hypothesis of psychiatric illness. Oxidative stress arises when reactive molecules, including hydrogen peroxide and hydroxyl radicals, are produced faster than cellular defense systems can neutralize them. The brain is particularly vulnerable because it consumes a disproportionate share of the body’s oxygen and is rich in lipids that are easily damaged by reactive species. Over the past two decades, researchers have reported abnormalities in antioxidant enzymes and molecules in patients with schizophrenia, depression, and bipolar disorder, but results have often been inconsistent, and few studies have tracked these markers longitudinally through an actual episode of illness and its treatment.

To fill that gap, the team led by Yujun Sun of Kunshan Mental Health Centre and colleagues at Suzhou Guangji Hospital of Soochow University recruited 70 inpatients with manic episodes of bipolar disorder from Wutai Mountain Hospital in Yangzhou, along with 70 age- and sex-matched healthy control subjects. All participants underwent standardized assessment of manic symptoms, and peripheral blood samples were collected to measure serum levels of a suite of oxidative stress markers: catalase, glutathione peroxidase, glutathione, hydrogen peroxide, hydroxyl radical, and total antioxidant capacity. The patients were then followed for four weeks of treatment, with symptom severity and blood markers reassessed at the end of that period.

The baseline comparisons revealed a distinctive oxidative profile in acute mania. Before treatment, patients showed significantly lower levels of catalase, glutathione peroxidase, glutathione, hydrogen peroxide, and hydroxyl radical than healthy controls, together with significantly higher total antioxidant capacity. At first glance, the elevated TAC in acutely manic patients may seem paradoxical, since antioxidant capacity might be expected to fall when defenses are overwhelmed. The authors interpret this pattern as evidence of a compensatory response: as the manic state imposes oxidative burden, the body appears to mobilize total antioxidant defenses upward, even as individual enzymatic components such as catalase and glutathione peroxidase are depleted or consumed.

Four weeks of treatment substantially changed the picture. Symptom severity, as measured by YMRS scores, decreased significantly over the follow-up period, a change the authors report with a t statistic of 46.220 and a P value below 0.001. Alongside clinical improvement, catalase, glutathione peroxidase, glutathione, and hydroxyl radical levels all rose significantly, while total antioxidant capacity fell. Notably, hydrogen peroxide levels, although improved, remained significantly lower in the patient group than in healthy controls even after four weeks of treatment, hinting that some aspects of redox balance recover more slowly than mood symptoms resolve.

The most clinically consequential result concerns prediction. Correlation analysis showed that the reduction in YMRS scores over the four weeks was significantly negatively associated with changes in TAC levels, with a correlation coefficient of −0.254 and a P value below 0.05. In other words, patients whose total antioxidant capacity declined the most tended to show the greatest symptomatic improvement. When the researchers turned to multivariate linear regression, three factors emerged as significant predictors of symptom improvement: the baseline YMRS score, the four-week change in TAC, and sex, all with P values below 0.05. The direction of the TAC finding fits the compensatory interpretation, since a falling TAC would parallel the normalization of an initially overactivated antioxidant response as mania subsides.

Several caveats deserve emphasis. The correlation coefficient, while statistically significant, describes a modest association, meaning that changes in TAC explain only a small fraction of the variability in treatment response. The study involved 70 patients at a single hospital, and the four-week window captures early response rather than long-term outcome. The researchers measured peripheral blood, not brain tissue, so the findings speak to systemic redox biology rather than directly to oxidative processes within neural circuits. Sex emerged as a predictor, but the study was not designed to dissect why, and the authors did not report mediation analyses that would clarify how demographic and biological variables interact. As with any observational follow-up study, association does not establish that antioxidant dynamics drive recovery; they may be a downstream echo of it.

Even with those limitations, the work carries real significance for a field hungry for biomarkers. Psychiatry has few laboratory tests to guide treatment decisions, and patients with bipolar mania often endure a trial-and-error process before an effective regimen is found. A marker that tracks, and potentially anticipates, clinical improvement could eventually help clinicians identify early non-responders, adjust treatment sooner, and monitor recovery objectively. The study also adds nuance to the oxidative stress hypothesis by showing that the relationship between antioxidant measures and illness is dynamic: TAC is elevated in acute mania and falls as symptoms lift, a pattern that static cross-sectional comparisons alone would have obscured.

The research, published open access on 6 October 2026 under DOI 10.1186/s12888-026-08734-2, was supported by funding from the Suzhou Key Technologies Program, the Suzhou Clinical Medical Center for Mood Disorders, and related regional programs. The authors emphasize that oxidative stress profiles in patients experiencing bipolar mania differ significantly from those of healthy individuals, with TAC emerging as a potential predictor of clinical improvement. Larger, multi-center studies with longer follow-up will be needed to confirm whether measuring total antioxidant capacity at the bedside can genuinely forecast who will respond to treatment. But the study marks a step toward a future in which a routine blood draw, read alongside clinical scales, becomes part of the standard assessment of manic illness, turning an abstract biochemical theory into a practical instrument of psychiatric care.

Subject of Research: Oxidative stress markers as predictors of treatment response in bipolar mania

Article Title: Total antioxidant capacity as a predictor of treatment response in bipolar mania: evidence from a 4-week follow-up study

Article References: Sun, Y., Wang, R., Wang, X., Yuan, S., Zhang, X., Zhang, X., & Sun, W. (2026). Total antioxidant capacity as a predictor of treatment response in bipolar mania: evidence from a 4-week follow-up study. BMC Psychiatry. https://doi.org/10.1186/s12888-026-08734-2

Image Credits: AI Generated

DOI: 10.1186/s12888-026-08734-2

Keywords: bipolar disorder, mania, oxidative stress, total antioxidant capacity, biomarkers, treatment response, catalase, glutathione peroxidase, glutathione, hydrogen peroxide, psychiatry, follow-up study